Navigation Links
Taiho Pharmaceutical presenta una solicitud para fabricar y comercializar el nuevo agente antitumoral TAS-102
Date:2/26/2013

on cáncer y continuará sus esfuerzos de desarrollo para ampliar su uso.   

Acerca de TAS-102
TAS-102 es un agente antitumoral compuesto por una combinación de trifluorotimidina (FTD), un nucleósido que se incorpora al ADN e inhibe una variedad de funciones genéticas requeridas para la proliferación de células cancerígenas, y tipiracil hidrocloruro (TPI), un inhibidor de timidine fosforilasa (que degrada FTD) que mantiene una concentración de sangre efectiva de FTD. TAS-102 se administra dos veces al día para lograr una dosis diaria total de 70 mg/metro cuadrado durante cinco días seguido por dos días el resto y luego repetido una segunda vez. A esto le sigue un period de 14 días de descanso para hacer un programa de 28 días para un curso.  

Acerca del ensayo clínico de fase II de TAS-102
El ensayo clínico de fase II se realizó con la participación de 172 pacientes en 20 instituciones médicas en Japón, de agosto de 2009 a abril de 2010. El objetivo para el estudio es un área para la cual actualmente no hay una terapia totalmente establecida en Japón; específicamente, pacientes que rechazan la quimioterapia estándar para el cáncer colorrectal metastásico que han recibido al menos dos o más regímenes con fluoropirimidina, irinotecan y oxaliplatin. Se asignó aleatoriamente a los pacientes TAS-102 (114 casos) o placebo (58 casos). La principal valoración fue la supervivencia general.  

Acerca del ensayo clínico de fase III global (RECOURSE)
El ensayo clínico de fase III global (RECOURSE) es un estudio comparativo aleatorio, de doble ciego de TAS-102 frente a placebo. Es un ensayo clínico de fase III global que está previsto para reclutar un total de 800 pacientes de Japón, Norteamérica, Europa y Aus
'/>"/>

SOURCE Taiho Pharmaceutical Co., Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Taiho Pharmaceutical stellt Zulassungsantrag zur Herstellung und Vermarktung des neuartigen Antitumormittels TAS-102
2. Taiho Pharmaceutical Submits Application for Approval to Manufacture and Market Novel Antitumor Agent TAS-102
3. Taiho Pharmaceutical présente une demande dhomologation pour la fabrication et la commercialisation du nouvel agent antitumoral TAS-102
4. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
5. Jazz Pharmaceuticals Reports Full Year And Fourth Quarter 2012 Financial Results
6. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Cowen & Company 33rd Annual Health Care Conference In Boston On March 5, 2013
7. Global Pharmaceutical Industry Trends: Procurement Budgets Stay the Same, Marketing Budgets to Experience Slight Decrease
8. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2012 Financial Results Conference Call on Tuesday, March 19, 2013
9. Savara Pharmaceuticals Announces Formation of Clinical Advisory Board
10. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
11. UBM Launches PharmaEvolution.com, an Online Peer-to-Peer Network for Pharmaceutical Industry Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... PITTSBURGH , Aug. 28, 2015 /PRNewswire/ ... that its shareholders have approved Mylan,s proposed acquisition ... TASE) and the related issuance of Mylan ordinary ... meeting of shareholders held today. The transaction received ... extraordinary general meeting. In addition, the transaction received ...
(Date:8/28/2015)... 28, 2015 The report "Eubiotics Market by Type ... Ruminant, and Aquaculture), & by Region ( North America ... , and Rest of the World) - Global Trends ... for Eubiotics was valued at USD 4.62 Billion in 2014 ... at a CAGR of 7.4% from 2015 to 2020. ...
(Date:8/28/2015)... LONDON , August 28, 2015 ... seamlessly connects people, technologies and care protoc ... improving outcomes and the cost of healthcare delivery   ... today announced its presence at  ESC Congress 2015 , where the ... A.I. , EchoNavigator and IntelliSpace Cardiovascular, that connect people and ...
Breaking Medicine Technology:Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 2Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 3Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 4
... FRANCISCO, Calif., Feb. 9, 2011 Rigel Pharmaceuticals, Inc. ... M. Gower, the company,s chairman and chief executive officer, ... New York City next week. Details of the events ... Annual BIO CEO & Investor ConferencePanel Topic:  "Rheumatoid Arthritis: ...
... Labs, Inc. (OTC Bulletin Board: GOVX), a ... vaccines, announced today the opening of a second clinical ... of the University of Alabama at Birmingham (UAB) to ... GeoVax vaccines are currently being tested clinically for HIV ...
Cached Medicine Technology:Rigel Announces Participation at Two Investor Conferences 2GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine 2GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine 3
(Date:8/30/2015)... ... August 31, 2015 , ... Negotiating an FDA Import Hold Crisis:, Strategies ... p.m. EDT, http://www.fdanews.com/importholdcrisis , US authorities are holding imports more than ever ... India. , With alerts on an uptick and a new final rule, having a ...
(Date:8/30/2015)... ... August 31, 2015 , ... ChopChop Kids, the nonprofit publisher ... recently elected two new officers to serve on the organization’s Board of Directors ... and teaching kids to cook real food with their families and help continue ...
(Date:8/30/2015)... ... August 30, 2015 , ... ... to announce that Partner Daniel M. Kotin was recently elected to membership in ... constitutes the highest degree of peer recognition and outstanding professionalism. , ABOTA ...
(Date:8/30/2015)... ... August 30, 2015 , ... Lizzie’s Lice Pickers , a company ... The company is currently offering lice head checks for just $10, which is a ... a 10% discount on their lice treatment products. “With kids returning to school, it ...
(Date:8/30/2015)... ... August 30, 2015 , ... InHealth Media ( http://www.inhealthmedia.com ) ... Communications Director for InHealth Media. Mr. Spector comes with a wide array ... doing on-air television, producing shows, on air-radio and media relations. , Brian ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — Negotiating an FDA Import Hold Crisis: Strategies for Challenging FDA Findings Webinar, Sept. 22, 2015 2Health News:FDAnews Announces — Negotiating an FDA Import Hold Crisis: Strategies for Challenging FDA Findings Webinar, Sept. 22, 2015 3Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 2Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 3Health News:Chicago Personal Injury Lawyer Daniel M. Kotin Elected to the American Board of Trial Advocates 2Health News:Chicago Personal Injury Lawyer Daniel M. Kotin Elected to the American Board of Trial Advocates 3Health News:Lizzie’s Lice Pickers Announces Back to School Head Check Special and Discounted Lice Treatment Products 2Health News:InHealth Media Appoints New Global Communications Director 2
... http://www.minuteclinic.com ), the pioneer and largest provider ... announced that it has become a,participating provider ... national provider of individual medical,small group and ... a MinuteClinic health care center, members enrolled ...
... Ltd., the biomedical,research group and developer of the ... Exempla Healthcare has contracted to utilize QDS,internet Quality ... QDS automates the gap between donor registration ... utilizes audio-visual touch screen computer,assisted donor self interviewing ...
... war on asthma symptom control could be a psychological one, ... and Dads leeriness towards their childrens asthma medications simply ... that outweigh the benefits might explain to some extent ... the wheezing, coughing and trouble-breathing disease do not take their ...
... by UT Southwestern Medical Center researchers has found that overweight ... high risk for iron deficiency. , Based on data ... that 20 percent of overweight toddlers were iron-deficient, compared to ... 7 percent of normal-weight toddlers. , The study, appearing ...
... weeks press release: , , Renal function and coronary ... mice by mesenchymal stem cells overexpressing angiopoietin 1, , , ... the links below to take your readers straight to ... ARTICLES WILL BE PUBLISHED ONLINE: , , Renal function and ...
... 28 at 11 a.m. in Nashville, NASHVILLE, ... leaders from Tennessee will hold a press conference ... granting the U.S.,Food and Drug Administration (FDA) authority ... entire Tennessee Congressional Delegation,particularly U.S. Representatives Bart Gordon ...
Cached Medicine News:Health News:MinuteClinic Becomes Participating Provider with Assurant Health 2Health News:MinuteClinic Becomes Participating Provider with Assurant Health 3Health News:Exempla Healthcare Contracts For Talisman's Quality Donor System 2Health News:Parents' perceptions can hamper kids' asthma care, study finds 2Health News:Parents' perceptions can hamper kids' asthma care, study finds 3Health News:Overweight toddlers and those not in day care at risk for iron deficiency 2Health News:Overweight toddlers and those not in day care at risk for iron deficiency 3Health News:Renal function and heart disease, and more 2Health News:Tennessee Faith Leaders Call on Reps. Gordon & Blackburn to Co-sponsor Legislation to Protect Kids from Tobacco 2
... Single Use linear stapler with LACTOMER™ ... Suture™ PREMIUM POLY CS™-57 disposable surgical ... of a temporary opening, such as ... section, or when transecting muscle tissue, ...
... Units With Titanium Staples for ... (Single Use Reloadable Stapler with ... Suture™ PREMIUM MULTIFIRE TA™ stapler ... pediatric and thoracic surgical procedures ...
... Single Use Loading Units for ... (Single Use Reloadable Staplers with ... Suture™ TA™ Reloadable staplers has ... and thoracic surgical procedures for ...
... linear stapler for resection, transection and anastomosis ... MULTIFIRE GIA™ 60 and 80 single use ... 80 single use loading units and the ... use surgical stapler with MULTIFIRE SGIA™ 60 ...
Medicine Products: